BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38765439)

  • 1. Sezary Syndrome: A Case Report and Review of Current Therapeutics.
    Krishnan J; Thanikachalam K
    Cureus; 2024 Apr; 16(4):e58570. PubMed ID: 38765439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracorporeal photophoresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(6):1-82. PubMed ID: 23074497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis.
    Stoll JR; Willner J; Oh Y; Pulitzer M; Moskowitz A; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1073-1090. PubMed ID: 33940098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides and Sézary syndrome.
    Jonak C; Tittes J; Brunner PM; Guenova E
    J Dtsch Dermatol Ges; 2021 Sep; 19(9):1307-1334. PubMed ID: 34541796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sézary Syndrome.
    Abreu Rocha C; Drummond Borges M; Santos GM; Sousa M; Teixeira T
    Cureus; 2023 Oct; 15(10):e46427. PubMed ID: 37927614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of bexarotene in mycosis fungoides and Sézary syndrome.
    Panchal MR; Scarisbrick JJ
    Onco Targets Ther; 2015; 8():367-73. PubMed ID: 25678803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.
    McCaffrey S; Black RA; Nagao M; Sepassi M; Sharma G; Thornton S; Kim YH; Braverman J
    J Med Internet Res; 2019 Jan; 21(1):e11302. PubMed ID: 30617041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
    Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
    J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment of Advanced-Stage Mycosis Fungoides and Sezary Syndrome: a Hematologist's Point of View.
    Giordano A; Pagano L
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022029. PubMed ID: 35444765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathologic studies in Sézary syndrome and erythrodermic mycosis fungoides: a comparison with benign forms of erythroderma.
    Sentis HJ; Willemze R; Scheffer E
    J Am Acad Dermatol; 1986 Dec; 15(6):1217-26. PubMed ID: 2948972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Characterization of Mogamulizumab-Associated Rash During Treatment of Mycosis Fungoides or Sézary Syndrome.
    Hirotsu KE; Neal TM; Khodadoust MS; Wang JY; Rieger KE; Strelo J; Hong E; Kim YH; Kwong BY
    JAMA Dermatol; 2021 Jun; 157(6):700-707. PubMed ID: 33881447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
    Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
    Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycosis fungoides and Sézary syndrome.
    Lee H
    Blood Res; 2023 Apr; 58(S1):66-82. PubMed ID: 37105561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mycosis fungoides and Sézary syndrome : a systematic review].
    André F; Guenova E; Blanchard G
    Rev Med Suisse; 2022 Mar; 18(775):578-589. PubMed ID: 35353453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N; Mahe A; Huerre M; Fraitag S; Valensi F; Macintyre E; Sanou F; de The G; Gessain A
    Leukemia; 1998 Apr; 12(4):578-85. PubMed ID: 9557617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome.
    Sethi TK; Montanari F; Foss F; Reddy N
    Br J Haematol; 2021 Nov; 195(3):352-364. PubMed ID: 33987825
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.